{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:34:54Z","timestamp":1787582094785,"version":"build-2736575974"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Metabolic dysfunction\u2013associated steatotic liver disease (MASLD) is the most common chronic liver disease of childhood and the hepatic component of a systemic metabolic and endocrine disorder linked to obesity and insulin resistance. Its psychological and social dimensions, however, remain under-recognized relative to its metabolic features. Affected children carry a substantial mental-health burden: elevated rates of depression, anxiety, disordered eating, and impaired quality of life that both reflect and aggravate the underlying disease. This mini review uses the biopsychosocial model to summarize current understanding of this burden in pediatric MASLD. We outline the bidirectional neuroendocrine and inflammatory mechanisms that link metabolic dysfunction with psychological distress, including cytokine signalling, leptin and adipokine dysregulation, hypothalamic\u2013pituitary\u2013adrenal axis activation, and the gut\u2013brain axis. We then consider the social determinants and system-level barriers that shape outcomes, practical approaches to screening and integrated multidisciplinary management, and the psychosocial considerations raised by emerging pharmacotherapies such as glucagon-like peptide-1 receptor agonists. We highlight areas of ongoing debate: notably the tension between weight-centred intervention and the risk of precipitating disordered eating, and the neuropsychiatric monitoring of new pharmacological agents, together with the principal research gaps and likely future directions. Recognizing pediatric MASLD as a biopsychosocial condition, and embedding mental-health assessment within routine metabolic care, may improve both hepatic and psychological outcomes in this growing population.<\/jats:p>","DOI":"10.3389\/fendo.2026.1916057","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:51:49Z","timestamp":1787579509000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychosocial aspects and mental health burden of pediatric MASLD"],"prefix":"10.3389","volume":"17","author":[{"given":"Vanishri","family":"Ganakumar","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (KAHER)","place":["Belgaum, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinay","family":"Mahaling","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (KAHER)","place":["Belgaum, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunath","family":"Goroshi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (KAHER)","place":["Belgaum, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Ghatnatti","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (KAHER)","place":["Belgaum, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1509232","article-title":"Global, regional, and national burden of NAFLD in youths and young adults aged 15\u201339 years, 1990\u20132021, its attributable risk factors, and projections to 2035: a systematic analysis of the Global Burden of Disease Study 2021","volume":"12","author":"Wang","year":"2025","journal-title":"Front Nutr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of fatty liver in children and adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12876-025-04314-y","article-title":"Global prevalence of metabolic dysfunction-associated fatty liver disease in children and adolescents with overweight and obesity: a systematic review and meta-analysis","volume":"25","author":"Jia","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2036.2009.04181.x","article-title":"Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease","volume":"31","author":"Kistler","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2018.09.001","article-title":"Psychosocial issues in pediatric nonalcoholic fatty liver disease","volume":"60","author":"Karaivazoglou","year":"2019","journal-title":"Psychosomatics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/mpg.0000000000003024","article-title":"Incidence of depression and anxiety in a cohort of adolescents with nonalcoholic fatty liver disease","volume":"72","author":"Noon","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.7871","article-title":"Paediatric non-alcoholic fatty liver disease: Impact on patients and mothers\u2019 quality of life","volume":"13","author":"Mazzone","year":"2013","journal-title":"Hepatitis Monthly"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/children10101595","article-title":"Specific learning disorders in children and adolescents with obesity","volume":"10","author":"Calcaterra","year":"2023","journal-title":"Children"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/00099228251330113","article-title":"A cross-sectional retrospective review of neuropsychiatric comorbidities in children with non-alcoholic fatty liver disease","volume":"64","author":"Sweeny","year":"2025","journal-title":"Clin Pediatr (Phila)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1017\/S0954579400007318","article-title":"Equifinality and multifinality in developmental psychopathology","volume":"8","author":"Cicchetti","year":"1996","journal-title":"Dev Psychopathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2016.05.012","article-title":"Internalizing\/externalizing problems: Review and recommendations for clinical and research applications","volume":"55","author":"Achenbach","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B13","first-page":"197","article-title":"Dimensional approaches to psychiatric diagnosis in DSM-5","volume":"14","author":"Narrow","year":"2011","journal-title":"J Ment Health Policy Econ"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2013.213","article-title":"The relationship between family functioning and child and adolescent overweight and obesity: a systematic review","volume":"38","author":"Halliday","year":"2014","journal-title":"Int J Obes"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13173","article-title":"Eating disorder risk in adolescents with obesity","volume":"22","author":"Jebeile","year":"2021","journal-title":"Obes Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1224612","article-title":"The role of neurochemicals, stress hormones and immune system in the positive feedback loops between diabetes, obesity and depression","volume":"14","author":"Wilson","year":"2023","journal-title":"Front Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.985803","article-title":"Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality","volume":"9","author":"Ng","year":"2022","journal-title":"Front Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1017\/S204579602000116X","article-title":"Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity","volume":"30","author":"Cho","year":"2021","journal-title":"Epidemiol Psychiatr Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11892-017-0923-y","article-title":"Shared dysregulation of homeostatic brain-body pathways in depression and type 2 diabetes","volume":"17","author":"Hoogendoorn","year":"2017","journal-title":"Curr Diabetes Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.01.014","article-title":"Immune system to brain signaling: Neuropsychopharmacological implications","volume":"130","author":"Capuron","year":"2011","journal-title":"Pharmacol Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: Impact on neurotransmitters and neurocircuits","volume":"30","author":"Miller","year":"2013","journal-title":"Depression Anxiety"},{"key":"B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: Inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126420","article-title":"Evidence that peripheral leptin resistance in omental adipose tissue and liver correlates with MASLD in humans","volume":"25","author":"De la Cruz-Color","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2010.3848","article-title":"Adipokines and redox signaling: Impact on fatty liver disease","volume":"15","author":"Parola","year":"2011","journal-title":"Antioxid Redox Signaling"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000639","article-title":"Adipokines regulate the development and progression of MASLD through organellar oxidative stress","volume":"9","author":"Zhao","year":"2025","journal-title":"Hepatol Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00271","article-title":"Hedonic eating and the \u201cdelicious circle\u201d: From lipid-derived mediators to brain dopamine and back","volume":"12","author":"Coccurello","year":"2018","journal-title":"Front Neurosci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01159","article-title":"Fructose: A dietary sugar in crosstalk with microbiota contributing to the development and progression of non-alcoholic liver disease","volume":"8","author":"Lambertz","year":"2017","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/nu10060761","article-title":"High-glucose or -fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change","volume":"10","author":"Do","year":"2018","journal-title":"Nutrients"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i8.108730","article-title":"Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies","volume":"17","author":"Al-Busafi","year":"2025","journal-title":"World J Hepatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.15698\/cst2025.06.305","article-title":"Pathogenic aspects of fructose consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): A narrative review","volume":"9","author":"Burger","year":"2025","journal-title":"Cell Stress"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314759","article-title":"Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression","volume":"67","author":"Stevens","year":"2018"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00392","article-title":"Breaking down the barriers: The gut microbiome, intestinal permeability and stress-related psychiatric disorders","volume":"9","author":"Kelly","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000518274","article-title":"Gut microbiota and pathophysiology of depressive disorder","volume":"77","author":"Kunugi","year":"2021","journal-title":"Ann Nutr Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.04.007","article-title":"The dichotomous effect of chronic stress on obesity","volume":"27","author":"Razzoli","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1119377","article-title":"The contribution of psychosocial stress to the obesity epidemic: An evolutionary approach","volume":"41","author":"Siervo","year":"2009","journal-title":"Horm Metab Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2011.04.024","article-title":"Inflammatory pathways in children with insufficient or disordered sleep","volume":"178","author":"Kim","year":"2011","journal-title":"Respir Physiol Neurobiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.08.014","article-title":"Sleep loss and inflammation","volume":"24","author":"Mullington","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/s40748-025-00225-8","article-title":"Weight gain in infancy and metabolic dysfunction-associated steatotic liver disease (MASLD) in a prospective birth cohort of Latino children","volume":"11","author":"Maxwell","year":"2025","journal-title":"Matern Health Neonatol Perinatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.603654","article-title":"New perspectives on genetic prediction for pediatric metabolic associated fatty liver disease","volume":"8","author":"Lin","year":"2020","journal-title":"Front Pediatr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00491","article-title":"Metabolic syndrome is associated with advanced liver fibrosis among pediatric patients with non-alcoholic fatty liver disease","volume":"7","author":"Ting","year":"2019","journal-title":"Front Pediatr"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000857","article-title":"Neighborhood disparities and metabolic dysfunction\u2013associated steatotic liver disease in children with overweight or obesity","volume":"9","author":"Venkatesh","year":"2025","journal-title":"Hepatol Commun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsab110","article-title":"Weight stigma and mental health in youth: A systematic review and meta-analysis","volume":"47","author":"Warnick","year":"2022","journal-title":"J Pediatr Psychol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxab057","article-title":"Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians","volume":"27","author":"Lee-Kim","year":"2022","journal-title":"Paediatr Child Health"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00367","article-title":"Referrals and management strategies for pediatric obesity\u2014DocStyles survey 2017","volume":"6","author":"Imoisili","year":"2018","journal-title":"Front Pediatr"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-014-0343-0","article-title":"Current approaches to the management of pediatric overweight and obesity","volume":"16","author":"Coppock","year":"2014","journal-title":"Curr Treat Options Cardio Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.8061","article-title":"Family-based behavioral treatment for childhood obesity implemented in pediatric primary care: A randomized clinical trial","volume":"329","author":"Epstein","year":"2023","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/15374416.2016.1163705","article-title":"Cognitive-behavioral therapy plus healthy lifestyle enhancement for depressed, overweight\/obese adolescents: Results of a pilot trial","volume":"48","author":"Jelalian","year":"2019","journal-title":"J Clin Child Adolesc Psychol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsz064","article-title":"Indirect effects of a cognitive-behavioral intervention on adolescent weight and insulin resistance through decreasing depression in a randomized controlled trial","volume":"44","author":"Gulley","year":"2019","journal-title":"J Pediatr Psychol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-040279","article-title":"Identification and management of eating disorders in children and adolescents","volume":"147","author":"Hornberger","year":"2021","journal-title":"Pediatrics"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2020.1806055","article-title":"Implementing psychological therapies for gastrointestinal disorders in pediatrics","volume":"14","author":"Reed","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jpn3.12060","article-title":"The impact of integrating behavioral health services into pediatric subspecialty care: A systematic review","volume":"78","author":"Sayegh","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity","volume":"387","author":"Weghuber","year":"2022","journal-title":"N Engl J Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02672-2","article-title":"Association of semaglutide with risk of suicidal ideation in a real-world cohort","volume":"30","author":"Wang","year":"2024","journal-title":"Nat Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jama.2025.26370","article-title":"FDA requests removal of suicidal ideation warning from GLP-1 RA medications","volume":"335","author":"Anderer","year":"2026","journal-title":"JAMA"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1093","article-title":"Transition of care model for pediatric patients with nonalcoholic fatty liver disease","volume":"18","author":"Mitrani","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1916057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:51:50Z","timestamp":1787579510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1916057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":55,"alternative-id":["10.3389\/fendo.2026.1916057"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1916057","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"1916057"}}